Crossmark

AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses

Published Online: 2016-04-18

Published Print: 2016-09

Authors

Gillissen, M A

de Jong, G

Levie, S E

Yasuda, E

Bakker, A Q

Evers, L M

Pals, S T

Huisman, C

van Helden, P M

Spits, H

Hazenberg, M D
License Information

Text and Data Mining valid from 2016-04-18

Version of Record valid from 2016-04-18
More Information

Article History

First Online: 18 April 2016

Competing interests

: The authors declare no conflict of interest.

Document is current